Lamotrigin Teva (Lamotrigine)

Lamotrigine blocks voltage‑gated sodium channels on neurons, stabilising the neuronal membrane and reducing the release of excitatory neurotransmitters such as glutamate. This action diminishes abnormal electrical activity that underlies seizures and mood swings.

The specific dose of Lamotrigin Teva is determined by the prescribing clinician based on the patient’s age, indication, renal and hepatic function, and any concomitant medications. Dose titration is typically gradual to minimise the risk of rash.

Lamotrigine’s safety profile in pregnancy is classified as unknown; it should only be used when the potential benefit outweighs the risk. Limited data suggest low transfer into breast milk, but clinicians should discuss potential risks with the mother before initiating therapy.

To request Lamotrigin Teva, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with carbamazepine, another anticonvulsant, lamotrigine has a lower risk of inducing hepatic enzyme activity and fewer drug‑induced hyponatraemia cases. However, lamotrigine requires slower titration to avoid rash, whereas carbamazepine may cause more dizziness and blood‑count changes.

Lamotrigin Teva tablets should be stored at or below 25 °C, in the original container, protected from moisture and direct sunlight. Keep the product out of reach of children and do not use after the expiry date printed on the packaging.

Lamotrigin Teva is taken orally, usually with or without food, as directed by the prescriber. Tablets should be swallowed whole with a glass of water; crushing or chewing is not recommended unless specifically advised.

The most serious risks include severe skin reactions such as Stevens‑Johnson syndrome or toxic epidermal necrolysis, blood dyscrasias, hepatic failure, and emergence of suicidal thoughts or behaviours. Patients should seek immediate medical attention if they develop a rash, fever, or mood changes.

Lamotrigine is contraindicated in individuals with a known hypersensitivity to lamotrigine or any component of the formulation. Caution is also advised for patients with severe hepatic impairment, a history of serious skin reactions, or those taking interacting enzyme‑inducing antiepileptic drugs without proper dose adjustment.